Compare Mongodb Inc (MDB) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mongodb Inc vs Mesoblast Limited — how do they compare? Mongodb Inc trades at $308 (market cap $26.01B), while Mesoblast Limited trades at $16.38 (market cap $2.17B). The key difference: Mongodb Inc is far larger — about 12× Mesoblast Limited's market cap. Which is the better fit depends on your goals.
| MDB | MESO | |
|---|---|---|
Market Cap | $26.01B | $2.17B |
Sector | Technology | Technology |
52-Week High | $440.25 | $20.96 |
52-Week Low | $201.08 | $12.88 |
Enterprise Value | $23.61B | $2.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
